NBIX
Neurocrine Biosciences Inc.
$152.80
-$1.95(-1.26%)
71
Overall
65
Value
72
Tech
76
Quality
Market Cap
$15.45B
Volume
948.91K
52W Range
$84.23 - $157.67
Target Price
$174.85
EPS Estimates Overview
| Current Quarter | $1.89 | Next Quarter | $1.39 |
| Current Year | $5.31 | Next Year | $7.13 |
| QoQ Growth | -26.5% | YoY Growth | +34.3% |
| 3Y EPS CAGR | +53.0% | Target Price | $174.85 |
| Consensus | Buy | Upside | +14.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NBIX | $152.80 | -1.3% | 948.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neurocrine Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW